Audited Results for the quarter and Year ende 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.8 pts less than Nifty Microcap 250 and 9.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tyche Industries reported FY25 total operating income of Rs 6,547.13 lakhs, down about 5.8% from Rs 6,950.97 lakhs in FY24. Total income (including other income) stood at Rs 7,288.65 lakhs vs Rs 7,543.24 lakhs. Despite the revenue dip, net profit after tax rose marginally to Rs 1,240.73 lakhs (FY24: Rs 1,224.29 lakhs), with EPS at Rs 12.49 vs Rs 11.78. Q4 FY25 was weaker — PAT dropped to Rs 94.43 lakhs from Rs 210.16 lakhs a year ago, on total income of Rs 1,437.05 lakhs (vs Rs 1,579.10 lakhs). Exports contributed Rs 1,215.35 lakhs in Q4 and Rs 4,408.06 lakhs for the full year. The board has recommended a final dividend of Rs 3.00 per share (30% on face value), subject to shareholder approval.
Mixed picture for shareholders: full-year profit held up despite a top-line decline, but Q4 numbers were notably weak. The 30% final dividend and clean (unmodified) auditor opinion are positives, though sluggish revenue and sharply lower Q4 earnings may cap near-term upside in the stock.